Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

ClinicalTrials.gov ID: NCT06955169

Public ClinicalTrials.gov record NCT06955169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 4:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma

Study identification

NCT ID: NCT06955169
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: RTOG Foundation, Inc.; Other
Enrollment: 153 participants

Conditions and interventions

Conditions

Intracranial Meningioma

Interventions

Standard of Care treatments Other
[177Lu]Lu-DOTATATE Drug

Other · Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 23, 2025
Primary completion: Jul 31, 2029
Completion: Jul 31, 2030
Last update posted: Apr 20, 2026

2025 – 2030

United States locations

U.S. sites: 11
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of California San Diego - Moores Cancer Center	La Jolla	California	92093	Recruiting
Yale University	New Haven	Connecticut	06520	Recruiting
Baptist MD Anderson Cancer Center	Jacksonville	Florida	32207	Recruiting
University of Miami	Miami	Florida	33146	Recruiting
Baptist Health Medical Group Oncology	Miami	Florida	33176	Recruiting
Piedmont Healthcare	Atlanta	Georgia	30318	Recruiting
Indiana University	Indianapolis	Indiana	46202	Recruiting
Dana-Farber/Harvard Cancer Center	Boston	Massachusetts	02215	Recruiting
University of Michigan Rogel Cancer Center	Ann Arbor	Michigan	48109	Recruiting
Duke University Medical Center	Durham	North Carolina	22708	Recruiting
Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06955169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 20, 2026 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06955169 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →